- By FYH News Team
[ad_1]
Retinopathy of prematurity (ROP) is a significant cause of childhood blindness and visual impairment around the world. It is a neovascular disease of the developing retina with a complex pathogenesis that is not fully understood. Low gestational age (GA), very low birth weight (BW), and hyperoxia are known dominant risk factors. Since the Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) trial, the question of the role of race on ROP has been debated. That large multicenter trial unexpectedly reported that Black infants had a lower incidence of threshold ROP compared with White infants.1 Other studies in North America2 and the United Kingdom3 supported this finding.
[ad_2]
Source link
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
- Jessica Wilson
- Jessica Wilson
- Jessica Wilson
